Last 12 months
Inside the activity.
0 purchase rows · 59 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 6 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 13 |
| Sep 2026 | 0 | 7 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2023 Filed Jun 9, 2023 20:17 UTC |
Brown Christopher D.Chief Product Officer
|
SaleCommon Stock | 4,470 | $10.03 | $44,834.10 |
DisclosureSEC source: 0001562180-23-005022 · primarydocument.xml · nonDerivative · entry 1 Brown Christopher D. · CIK 0001836988 · Chief Product Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 897,905 F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.08, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 07, 2023 Filed Jun 14, 2023 20:14 UTC |
Eisenberg MarciaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 681 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005151 · primarydocument.xml · derivative · entry 2 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 682 Underlying: Common Stock · 1,363 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F2 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 3 years following June 7, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 3 years following June 7, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 07, 2023 Filed Jun 14, 2023 20:14 UTC |
Eisenberg MarciaDirector
|
Exercise / conversionCommon Stock | 681 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-005151 · primarydocument.xml · nonDerivative · entry 1 Eisenberg Marcia · CIK 0001866723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. Read SEC document |
| June 05, 2023 Filed Jun 5, 2023 20:07 UTC |
Knopp Kevin J.Director · President and CEO
|
Exercise / conversionStock Option (option to buy) · Derivative | 28,500 | $1.75 Strike: $1.75 | $49,875.00 |
DisclosureSEC source: 0001562180-23-004774 · primarydocument.xml · derivative · entry 3 Knopp Kevin J. · CIK 0001836523 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,418 Underlying: Common Stock · 122,918 shares Expires 2027-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares underlying the option are fully vested and immediately exercisable. Read SEC document |
| June 05, 2023 Filed Jun 5, 2023 20:07 UTC |
Knopp Kevin J.Director · President and CEO
|
Exercise / conversionCommon Stock | 28,500 | $1.75 | $49,875.00 |
DisclosureSEC source: 0001562180-23-004774 · primarydocument.xml · nonDerivative · entry 1 Knopp Kevin J. · CIK 0001836523 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 396,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:12 UTC |
Brown Christopher D.Chief Technology Officer
|
SaleCommon Stock, par value $0.001 | 10,000 | $10.02 | $100,200.00 |
DisclosureSEC source: 0001562180-23-004482 · primarydocument.xml · nonDerivative · entry 1 Brown Christopher D. · CIK 0001836988 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 892,375 F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.09, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:08 UTC |
Knopp Kevin J.Director · President and CEO
|
SaleCommon Stock, par value $0.001 | 60,000 | $10.12 | $607,200.00 |
DisclosureSEC source: 0001562180-23-004480 · primarydocument.xml · nonDerivative · entry 1 Knopp Kevin J. · CIK 0001836523 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 367,848 F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.37, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 22, 2023 Filed Mar 23, 2023 21:38 UTC |
Griffith Joseph H. IVChief Financial Officer
|
Exercise / conversionStock Option (option to buy) · Derivative | 5,000 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001562180-23-003085 · primarydocument.xml · derivative · entry 2 Griffith Joseph H. IV · CIK 0001431531 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,437 Underlying: Common Stock, par value $0.001 · 5,000 shares Expires 2029-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares underlying the option are fully vested and immediately exercisable. Read SEC document |
| March 22, 2023 Filed Mar 23, 2023 21:38 UTC |
Griffith Joseph H. IVChief Financial Officer
|
Exercise / conversionCommon Stock, par value $0.001 | 5,000 | $1.58 | $7,900.00 |
DisclosureSEC source: 0001562180-23-003085 · primarydocument.xml · nonDerivative · entry 1 Griffith Joseph H. IV · CIK 0001431531 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2023 Filed Mar 7, 2023 21:20 UTC |
Hunt AnthonyDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,058 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002561 · primarydocument.xml · derivative · entry 2 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,115 Underlying: Common Stock, par value $0.001 · 6,173 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F2 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 3 years following March 2, 2022, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 3 years following March 2, 2022, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| March 02, 2023 Filed Mar 7, 2023 21:20 UTC |
Hunt AnthonyDirector
|
Exercise / conversionCommon Stock, par value $0.001 | 2,058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-002561 · primarydocument.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. Read SEC document |
| March 01, 2023 Filed Mar 16, 2023 20:33 UTC |
Griffith Joseph H. IVChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 41,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002860 · primarydocument.xml · derivative · entry 2 Griffith Joseph H. IV · CIK 0001431531 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,224 Underlying: Common Stock, par value $0.001 · 41,224 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F3 · derivative.exercise_date: The RSUs shall vest 25% on February 1, 2024, with the remaining 75% vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. F3 · derivative.expiration_date: The RSUs shall vest 25% on February 1, 2024, with the remaining 75% vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. Read SEC document |
| March 01, 2023 Filed Mar 16, 2023 20:33 UTC |
Griffith Joseph H. IVChief Financial Officer
|
GrantStock Option (option to buy) · Derivative | 62,543 | $0.00 Strike: $8.83 | $0.00 |
DisclosureSEC source: 0001562180-23-002860 · primarydocument.xml · derivative · entry 1 Griffith Joseph H. IV · CIK 0001431531 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,543 Underlying: Common Stock, par value $0.001 · 62,543 shares Expires 2033-02-28 F1 · derivative.exercise_date: Twenty-five percent of the shares underlying the option become vested and exercisable on February 1, 2024, and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| March 01, 2023 Filed Mar 16, 2023 20:33 UTC |
Brown Christopher D.Chief Technology Officer
|
GrantRestricted Stock Unit · Derivative | 29,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002861 · primarydocument.xml · derivative · entry 2 Brown Christopher D. · CIK 0001836988 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,672 Underlying: Common Stock, par value $0.001 · 29,672 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F3 · derivative.exercise_date: The RSUs shall vest 25% on February 1, 2024, with the remaining 75% vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. F3 · derivative.expiration_date: The RSUs shall vest 25% on February 1, 2024, with the remaining 75% vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. Read SEC document |
| March 01, 2023 Filed Mar 16, 2023 20:33 UTC |
Brown Christopher D.Chief Technology Officer
|
GrantStock Option (option to buy) · Derivative | 45,018 | $0.00 Strike: $8.83 | $0.00 |
DisclosureSEC source: 0001562180-23-002861 · primarydocument.xml · derivative · entry 1 Brown Christopher D. · CIK 0001836988 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,018 Underlying: Common Stock, par value $0.001 · 45,018 shares Expires 2033-02-28 F1 · derivative.exercise_date: Twenty-five percent of the shares underlying the option become vested and exercisable on February 1, 2024, and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| March 01, 2023 Filed Mar 16, 2023 20:33 UTC |
Turner Michael S.VP, General Counsel
|
GrantRestricted Stock Unit · Derivative | 39,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002859 · primarydocument.xml · derivative · entry 2 Turner Michael S. · CIK 0001836524 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,638 Underlying: Common Stock, par value $0.001 · 39,638 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F3 · derivative.exercise_date: The RSUs shall vest 25% on February 1, 2024, with the remaining 75% vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. F3 · derivative.expiration_date: The RSUs shall vest 25% on February 1, 2024, with the remaining 75% vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. Read SEC document |
| March 01, 2023 Filed Mar 16, 2023 20:33 UTC |
Turner Michael S.VP, General Counsel
|
GrantStock Option (option to buy) · Derivative | 60,138 | $0.00 Strike: $8.83 | $0.00 |
DisclosureSEC source: 0001562180-23-002859 · primarydocument.xml · derivative · entry 1 Turner Michael S. · CIK 0001836524 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,138 Underlying: Common Stock, par value $0.001 · 60,138 shares Expires 2033-02-28 F1 · derivative.exercise_date: Twenty-five percent of the shares underlying the option become vested and exercisable on February 1, 2024, and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| March 01, 2023 Filed Mar 16, 2023 20:32 UTC |
Knopp Kevin J.Director · President and CEO
|
GrantPerformance-Based Restricted Stock Unit · Derivative | 53,794 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002858 · primarydocument.xml · derivative · entry 2 Knopp Kevin J. · CIK 0001836523 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,794 Underlying: Common Stock, par value $0.001 · 53,794 shares Expires not disclosed F3 · derivative.exercise_price: Each Performance-Based RSU represents a contingent right to receive one share of Common Stock, when vested. The actual number of shares of Common Stock earned and acquired upon vesting of the Performance-Based RSUs shall be based upon the achievement of stock price levels pre-established by the Compensation Committee at the grant date, which shall be determined and certified by the Compensation Committee within 30 days of December 31, 2025, with reference to the Company's volume weighted average price of Common Stock on The Nasdaq Global Market during the fourth calendar quarter of fiscal year 2025 (i.e., the period from October 1, 2025 to December 31, 2025), subject to the reporting person's continued service through the vesting date. The number of Performance-Based RSUs reported reflects the maximum number of units the reporting person may earn at the certification date. Any Performance-Based RSUs not earned at the certification date shall be forfeited. F3 · derivative.exercise_date: Each Performance-Based RSU represents a contingent right to receive one share of Common Stock, when vested. The actual number of shares of Common Stock earned and acquired upon vesting of the Performance-Based RSUs shall be based upon the achievement of stock price levels pre-established by the Compensation Committee at the grant date, which shall be determined and certified by the Compensation Committee within 30 days of December 31, 2025, with reference to the Company's volume weighted average price of Common Stock on The Nasdaq Global Market during the fourth calendar quarter of fiscal year 2025 (i.e., the period from October 1, 2025 to December 31, 2025), subject to the reporting person's continued service through the vesting date. The number of Performance-Based RSUs reported reflects the maximum number of units the reporting person may earn at the certification date. Any Performance-Based RSUs not earned at the certification date shall be forfeited. F3 · derivative.expiration_date: Each Performance-Based RSU represents a contingent right to receive one share of Common Stock, when vested. The actual number of shares of Common Stock earned and acquired upon vesting of the Performance-Based RSUs shall be based upon the achievement of stock price levels pre-established by the Compensation Committee at the grant date, which shall be determined and certified by the Compensation Committee within 30 days of December 31, 2025, with reference to the Company's volume weighted average price of Common Stock on The Nasdaq Global Market during the fourth calendar quarter of fiscal year 2025 (i.e., the period from October 1, 2025 to December 31, 2025), subject to the reporting person's continued service through the vesting date. The number of Performance-Based RSUs reported reflects the maximum number of units the reporting person may earn at the certification date. Any Performance-Based RSUs not earned at the certification date shall be forfeited. Read SEC document |
| March 01, 2023 Filed Mar 16, 2023 20:32 UTC |
Knopp Kevin J.Director · President and CEO
|
GrantRestricted Stock Unit · Derivative | 53,794 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-002858 · primarydocument.xml · derivative · entry 1 Knopp Kevin J. · CIK 0001836523 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,794 Underlying: Common Stock, par value $0.001 · 53,794 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001 ("Common Stock"), when vested. F2 · derivative.exercise_date: The RSUs shall vest 25% on February 1, 2024, with the remaining 75% vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs shall vest 25% on February 1, 2024, with the remaining 75% vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 21:28 UTC |
George Jeffrey P.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 507 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001756 · primarydocument.xml · derivative · entry 2 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 508 Underlying: Common Stock, par value $0.001 · 1,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F2 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 3 years following February 22, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 3 years following February 22, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 21:28 UTC |
George Jeffrey P.Director
|
Exercise / conversionCommon Stock, par value $0.001 | 507 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-001756 · primarydocument.xml · nonDerivative · entry 1 George Jeffrey P. · CIK 0001796789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 21:33 UTC |
ELOI FENEL MDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 507 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001759 · primarydocument.xml · derivative · entry 2 ELOI FENEL M · CIK 0001237190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 508 Underlying: Common Stock, par value $0.001 · 1,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F2 · derivative.exercise_date: The RSUs become vested in substantially equal annual installments over the 3 years following February 22, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs become vested in substantially equal annual installments over the 3 years following February 22, 2021, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 21:33 UTC |
ELOI FENEL MDirector
|
Exercise / conversionCommon Stock, par value $0.001 | 507 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-001759 · primarydocument.xml · nonDerivative · entry 1 ELOI FENEL M · CIK 0001237190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:06 UTC |
Knopp Kevin J.Director · President and CEO
|
SaleCommon Stock, par value $0.001 | 4,842 | $10.12 | $49,001.04 |
DisclosureSEC source: 0001562180-23-001491 · primarydocument.xml · nonDerivative · entry 2 Knopp Kevin J. · CIK 0001836523 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,848 F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.26, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:06 UTC |
Knopp Kevin J.Director · President and CEO
|
SaleCommon Stock, par value $0.001 | 15,158 | $10.29 | $155,975.82 |
DisclosureSEC source: 0001562180-23-001491 · primarydocument.xml · nonDerivative · entry 1 Knopp Kevin J. · CIK 0001836523 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,690 F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.20 to $10.42, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:16 UTC |
Griffith Joseph H. IVChief Financial Officer
|
SaleCommon Stock | 3,266 | $10.03 | $32,757.98 |
DisclosureSEC source: 0001562180-23-000967 · primarydocument.xml · nonDerivative · entry 3 Griffith Joseph H. IV · CIK 0001431531 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,580 F4 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.15, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:17 UTC |
Turner Michael S.VP, General Counsel
|
SaleCommon Stock | 2,848 | $10.02 | $28,536.96 |
DisclosureSEC source: 0001562180-23-000969 · primarydocument.xml · nonDerivative · entry 3 Turner Michael S. · CIK 0001836524 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.08, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:16 UTC |
Knopp Kevin J.Director · President and CEO
|
SaleCommon Stock | 40,000 | $10.51 | $420,400.00 |
DisclosureSEC source: 0001562180-23-000968 · primarydocument.xml · nonDerivative · entry 3 Knopp Kevin J. · CIK 0001836523 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,848 F4 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.89, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:14 UTC |
Brown Christopher D.Chief Technology Officer
|
SaleCommon Stock | 10,000 | $10.03 | $100,300.00 |
DisclosureSEC source: 0001562180-23-000965 · primarydocument.xml · nonDerivative · entry 3 Brown Christopher D. · CIK 0001836988 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 902,375 F4 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.19, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:16 UTC |
Griffith Joseph H. IVChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000967 · primarydocument.xml · derivative · entry 4 Griffith Joseph H. IV · CIK 0001431531 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,307 Underlying: Common Stock · 5,102 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F6 · derivative.exercise_date: The 5,102 RSUs vested on February 1, 2023, with the remaining 15,307 RSUs vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. F6 · derivative.expiration_date: The 5,102 RSUs vested on February 1, 2023, with the remaining 15,307 RSUs vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:16 UTC |
Griffith Joseph H. IVChief Financial Officer
|
SaleCommon Stock | 1,836 | $9.17 | $16,836.12 |
DisclosureSEC source: 0001562180-23-000967 · primarydocument.xml · nonDerivative · entry 2 Griffith Joseph H. IV · CIK 0001431531 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,846 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.98 to $9.63, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:16 UTC |
Griffith Joseph H. IVChief Financial Officer
|
Exercise / conversionCommon Stock | 5,102 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-000967 · primarydocument.xml · nonDerivative · entry 1 Griffith Joseph H. IV · CIK 0001431531 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:17 UTC |
Turner Michael S.VP, General Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,427 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000969 · primarydocument.xml · derivative · entry 4 Turner Michael S. · CIK 0001836524 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,281 Underlying: Common Stock · 4,427 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F6 · derivative.exercise_date: The 4,427 RSUs vested on February 1, 2023, with the remaining 13,281 RSUs vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. F6 · derivative.expiration_date: The 4,427 RSUs vested on February 1, 2023, with the remaining 13,281 RSUs vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:17 UTC |
Turner Michael S.VP, General Counsel
|
SaleCommon Stock | 1,579 | $9.17 | $14,479.43 |
DisclosureSEC source: 0001562180-23-000969 · primarydocument.xml · nonDerivative · entry 2 Turner Michael S. · CIK 0001836524 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,848 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.63, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:17 UTC |
Turner Michael S.VP, General Counsel
|
Exercise / conversionCommon Stock | 4,427 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-000969 · primarydocument.xml · nonDerivative · entry 1 Turner Michael S. · CIK 0001836524 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:16 UTC |
Knopp Kevin J.Director · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000968 · primarydocument.xml · derivative · entry 5 Knopp Kevin J. · CIK 0001836523 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,764 Underlying: Common Stock · 11,255 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F7 · derivative.exercise_date: The 11,255 RSUs vested on February 1, 2023, with the remaining 33,764 RSUs vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. F7 · derivative.expiration_date: The 11,255 RSUs vested on February 1, 2023, with the remaining 33,764 RSUs vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:16 UTC |
Knopp Kevin J.Director · President and CEO
|
SaleCommon Stock | 4,049 | $9.36 | $37,898.64 |
DisclosureSEC source: 0001562180-23-000968 · primarydocument.xml · nonDerivative · entry 2 Knopp Kevin J. · CIK 0001836523 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,848 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.98 to $9.63, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:16 UTC |
Knopp Kevin J.Director · President and CEO
|
Exercise / conversionCommon Stock | 11,255 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-000968 · primarydocument.xml · nonDerivative · entry 1 Knopp Kevin J. · CIK 0001836523 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:15 UTC |
Fitzpatrick MauraVP, Product Management & Mktg
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,427 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000966 · primarydocument.xml · derivative · entry 3 Fitzpatrick Maura · CIK 0001927742 · VP, Product Management & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,281 Underlying: Common Stock · 4,427 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F4 · derivative.exercise_date: The 4,427 RSUs vested on February 1, 2023, with the remaining 13,281 RSUs vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. F4 · derivative.expiration_date: The 4,427 RSUs vested on February 1, 2023, with the remaining 13,281 RSUs vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:15 UTC |
Fitzpatrick MauraVP, Product Management & Mktg
|
SaleCommon Stock | 1,593 | $9.20 | $14,655.60 |
DisclosureSEC source: 0001562180-23-000966 · primarydocument.xml · nonDerivative · entry 2 Fitzpatrick Maura · CIK 0001927742 · VP, Product Management & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,834 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.01 to $9.63, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:15 UTC |
Fitzpatrick MauraVP, Product Management & Mktg
|
Exercise / conversionCommon Stock | 4,427 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-000966 · primarydocument.xml · nonDerivative · entry 1 Fitzpatrick Maura · CIK 0001927742 · VP, Product Management & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:14 UTC |
Brown Christopher D.Chief Technology Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000965 · primarydocument.xml · derivative · entry 4 Brown Christopher D. · CIK 0001836988 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,082 Underlying: Common Stock · 5,027 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F6 · derivative.exercise_date: The 5,027 RSUs vested on February 1, 2023, with the remaining 15,082 RSUs vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. F6 · derivative.expiration_date: The 5,027 RSUs vested on February 1, 2023, with the remaining 15,082 RSUs vesting in three substantially equal annual installments at the three anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:14 UTC |
Brown Christopher D.Chief Technology Officer
|
SaleCommon Stock | 1,564 | $9.17 | $14,341.88 |
DisclosureSEC source: 0001562180-23-000965 · primarydocument.xml · nonDerivative · entry 2 Brown Christopher D. · CIK 0001836988 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 912,375 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.98 to $9.69, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:14 UTC |
Brown Christopher D.Chief Technology Officer
|
Exercise / conversionCommon Stock | 5,027 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-000965 · primarydocument.xml · nonDerivative · entry 1 Brown Christopher D. · CIK 0001836988 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 913,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| December 19, 2022 Filed Feb 14, 2023 19:30 UTC |
HRUSOVSKY E KEVINDirector
|
GiftCommon Stock | 193,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001395 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 329,675 F1 · kind: On December 19, 2022, 193,176 shares of the Issuer's Common Stock were transferred from the reporting person to the E. Kevin Hrusovsky 2012 Irrevocable Trust. This was a bona fide gift with no payment in consideration. F1 · price: On December 19, 2022, 193,176 shares of the Issuer's Common Stock were transferred from the reporting person to the E. Kevin Hrusovsky 2012 Irrevocable Trust. This was a bona fide gift with no payment in consideration. F2 · ownership.nature: The securities are owned directly by the E. Kevin Hrusovsky 2012 Irrevocable Trust. The reporting person's spouse and children are trustees of E. Kevin Hrusovsky 2012 Irrevocable Trust and have joint voting and dispositive control with respect to all securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust and the reporting person may be deemed to be the beneficial owner of the securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust. Read SEC document |
| December 19, 2022 Filed Feb 14, 2023 19:30 UTC |
HRUSOVSKY E KEVINDirector
|
GiftCommon Stock | 193,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001395 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,395 F1 · kind: On December 19, 2022, 193,176 shares of the Issuer's Common Stock were transferred from the reporting person to the E. Kevin Hrusovsky 2012 Irrevocable Trust. This was a bona fide gift with no payment in consideration. F1 · price: On December 19, 2022, 193,176 shares of the Issuer's Common Stock were transferred from the reporting person to the E. Kevin Hrusovsky 2012 Irrevocable Trust. This was a bona fide gift with no payment in consideration. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:38 UTC |
Spoto MarkDirector
|
PurchaseCommon Stock, par value $0.001 | 2,585 | $9.65 | $24,945.25 |
DisclosureSEC source: 0001562180-22-007879 · primarydocument.xml · nonDerivative · entry 1 Spoto Mark · CIK 0001836585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,423 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 16:06 UTC |
HRUSOVSKY E KEVINDirector
|
Exercise / conversionStock Option (option to buy) · Derivative | 76,016 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001562180-22-007809 · primarydocument.xml · derivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 76,016 shares Expires 2023-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares underlying the option are fully vested and immediately exercisable. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 16:06 UTC |
HRUSOVSKY E KEVINDirector
|
Exercise / conversionCommon Stock, par value $0.001 | 76,016 | $0.35 | $26,605.60 |
DisclosureSEC source: 0001562180-22-007809 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:25 UTC |
Knopp Kevin J.Director · President and CEO
|
SaleCommon Stock, par value $0.001 | 1,013 | $12.40 | $12,561.20 |
DisclosureSEC source: 0001562180-22-007738 · primarydocument.xml · nonDerivative · entry 3 Knopp Kevin J. · CIK 0001836523 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,642 F1 · kind: Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.23 to $12.70, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.